BioCentury | May 11, 2009
Clinical News

Felbatol felbamate regulatory update

...tiagabine from Cephalon; Lyrica pregabalin from Pfizer; and the generics carbamazepine, clonazepam, clorazepate, divalproex sodium, ethosuximide...
BioCentury | May 6, 2009
Company News

Antiepileptics get updated labels

...NASDAQ:CEPH); Lyrica pregabalin from Pfizer Inc. (NYSE:PFE); and the generics carbamazepine, clonazepam, clorazepate, divalproex sodium, ethosuximide...
BioCentury | Dec 22, 2008
Clinical News

Gabitril tiagabine regulatory update

...from Pfizer; Topamax topiramate from Johnson & Johnson; and the generics carbamazepine; clonazepam; clorazepate; divalproex; ethosuximide...
BioCentury | Dec 17, 2008
Company News

Antiepileptics to get suicidality warning

...Topamax topiramate from Johnson & Johnson (NYSE:JNJ); and the generics carbamazepine; clonazepam; clorazepate; divalproex sodium; ethosuximide...
BioCentury | Oct 13, 1997
Strategy

CoCensys remodels its model

...COCN had recently lost co-promotion of Parke-Davis' Cognex for Alzheimer's disease, but had acquired Parke-Davis' Zarontin...
...the president of the division, Rick Henson. Watson also will acquire COCN's co-promotion agreements for Zarontin...
...COCN had recently lost co-promotion of Parke-Davis' Cognex for Alzheimer's disease, but had acquired Parke-Davis' Zarontin...
BioCentury | Oct 13, 1997
Company News

CoCensys, Watson deal

...acquire COCN's co-promotion agreements to market Somerset Pharmaceuticals' Eldepryl selegiline for Parkinson's disease and Parke-Davis' Zarontin...
BioCentury | Jul 7, 1997
Company News

CoCensys, Parke-Davis sales and marketing update

...COCN will exclusively market Parke-Davis's Zarontin pediatric epilepsy drug to neurologists in the U.S. COCN and...
Items per page:
1 - 7 of 7